Neuralytix, a spine medtech company, made its iD3 System fully commercially available Aug. 4 through its U.S. distributor network.
The mechanomyography platform is designed to give spine surgeons real-time, objective feedback on neurophysiologic changes occurring throughout decompression surgery, according to an Aug. 4 news release from the company. The full rollout follows the system’s initial commercial release in October.
The surgeon-directed system requires no dedicated technician or neurophysiologist and integrates directly into existing surgical workflow, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
